Search

A key focus of the partnership will be the development of adeno-associated virus gene therapy programs using intellectual property from KU Leuven

Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies

The new site is still within the Midlothian Science Zone and is now fully operational, marking a significant milestone in the company’s continued growth

Discover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development

The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease and therapeutic drug monitoring

Learn how you can transform cell therapy screening workflows at all stages of research

Logos Biosystems, SPT Labtech and BMG LABTECH among those recognized

Nuvec is N4 Pharma’s proprietary gene delivery system being developed to safely and effectively transport RNA therapies for cancer and other diseases

Due to its precise analytical performance, the HLC-723 GR01 enhances diagnostic confidence, supporting both high throughput and improved diabetes care

Introducing Cheetah™ FLEX and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerases for qPCR, PEA, and NGS-based PEA workflows